Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Psychiatr Q. 2017 Sep;88(3):545–552. doi: 10.1007/s11126-016-9468-5

Table 1.

Demographic information and clinical characteristics (n = 18)

Age, yr mean (SD) [range yr] 36.4 (12.5) [20–56]
Male, n (%) 11 (61.1)
Caucasian, n (%) 10 (55.6)
Special diet, n (%) 8 (44.4)
Smoker, n (%) 12 (67.7)
Diabetes mellitus type 2, n (%) 2 (11.1)
Hyperlipidemia, n (%) 6 (33.3)
Hypertension, n (%) 2 (11.1)
Polydipsia, n (%) 2 (11.1)
Maximum stabilized CLZ dose, mg/day mean (SD) [range mg/day] 441.7 (171.8) [100–800]
CLZ level, mcg/L mean (SD) [range mcg/L] 386.9 (177.7) [91–835]
Norclozapine level, mcg/L mean (SD) [range mcg/L] 210.9 (97.7) [31–595]
Total CLZ level, mcg/L mean (SD) [range mcg/L] 603.9 (263.0) [122–1430]

Special diet includes the following: low salt, low cholesterol, high protein, gluten free or high calorie